Effect of a Japanese drug alert pictogram on medication-taking/driving behavior

References

• Barros IM, Alcântara TS, Mesquita AR, Santos AC, Paixão FP, Lyra DP. Jr.2014. The use of pictograms in the health care: a literature review. Res Soc Adm Pharm. 10(5):704–719. doi: 10.1016/j.sapharm.2013.11.002
   PubMed Web of Science ®Google Scholar
• Davis RE, Dolan G, Thomas S, Atwell C, Mead D, Nehammer S, Moseley L, Edwards A, Elwyn G. 2003. Exploring doctor and patient views about risk communication and shared decision-making in the consultation. Health Expect. 6(3):198–207. doi: 10.1046/j.1369-6513.2003.00235.x
   PubMedGoogle Scholar
• Edwards A, Elwyn G, Hood K, Robling M, Atwell C, Holmes-Rovner M, Kinnersley P, Houston H, Russell I. 2003. The development of COMRADE—a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. Patient Educ Couns. 50(3):311–322. doi: 10.1016/s0738-3991(03)00055-7
   PubMed Web of Science ®Google Scholar
• Emich B, van Dijk L, Monteiro SP, de Gier JJ. 2014. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines. Int J Clin Pharm. 36(6):1152–1159.
   PubMed Web of Science ®Google Scholar
• Fierro I, Gómez-Talegón T, Alvarez FJ. 2013. The Spanish pictogram on medicines and driving: The population’s comprehension of and attitudes towards its use on medication packaging. Accid Anal Prev. 50:1056–1061. doi: 10.1016/j.aap.2012.08.009
   PubMed Web of Science ®Google Scholar
• Gómez-Talegón T, Fierro I, del Rio MC, Álvarez FJ. 2011. Establishment of framework for classification/categorisation and labelling of medicinal drugs and driving. Germany: Federal Highway Research Institute; [accessed 2018 Dec 12]. https://www.bast.de/Druid/EN/deliverales-list/downloads/Deliverable_4_3.htm.
   Google Scholar
• Gutierrez-Abejón E, Herrera-Gómez F, Criado-Espegel P, Alvarez FJ. 2017. Use of driving-impairing medicines by a Spanish population: a population-based registry study. BMJ Open. 7(11):e017618. doi: 10.1136/bmjopen-2017-017618
   PubMed Web of Science ®Google Scholar
• Hetland AJ, Carr DB, Wallendorf MJ, Barco PP. 2014. Potentially driver-impairing (PDI) medication use in medically impaired adults referred for driving evaluation. Ann Pharmacother. 48(4):476–482. doi: 10.1177/1060028014520881
   PubMed Web of Science ®Google Scholar
• Imanishi T, Takamatsu C, Takayama A. 2017. Creation of pictograms regarding pharmacological effects of medicine: The necessity and evaluation of created pictograms. Jpn J Pharmaceut Health Care Sci. 43(11):640–647. doi: 10.5649/jjphcs.43.640. (in Japanese)
   Google Scholar
• Mansoor L, Dowse R. 2003. Effect of pictograms on readability of patient information materials. Ann Pharmacother. 37(7-8):1003–1009. doi: 10.1345/aph.1C449.
   PubMed Web of Science ®Google Scholar
• Mcdougall SJP, Curry MB, de Bruijn O. 1999. Measuring symbol and icon characteristics: Norms for concreteness, complexity, meaningfulness, familiarity, and semantic distance for 239 symbols. Behav Res Methods Instrum Comput. 31(3):487–519. doi: 10.3758/BF03200730
   PubMedGoogle Scholar
• McGwin G, Jr., Sims RV, Pulley L, Roseman JM. 2000. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: A population-based case-control study. Am J Epidemiol. 152(5):424–431. doi: 10.1093/aje/152.5.424
   PubMed Web of Science ®Google Scholar
• Medsafe.Net. 2007. Trends surrounding medical safety n.d. [accessed 2018 Dec 12] http://www.medsafe.net/contents/recent/96emoji.html. (in Japanese)
   Google Scholar
• Monteiro SP, Huiskes R, Van Dijk L, Van Weert JC, De Gier JJ. 2013. How effective are pictograms in communicating risk about driving-impairing medicines?. Traffic Inj Prev. 14(3):299–308. doi: 10.1080/15389588.2012.710766
   PubMed Web of Science ®Google Scholar
• Nutbeam D. 2000. Health literacy as a public health goal: A challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 15(3):259–267. doi: 10.1093/heapro/15.3.259
   Web of Science ®Google Scholar
• Orriols L, Delorme B, Gadegbeku B, Tricotel A, Contrand B, Laumon B, Salmi LR, Lagarde E; CESIR research group. 2010. Prescription medicines and the risk of road traffic crashes: A French registry-based study. PLoS Med. 7(11):e1000366. doi: 10.1371/journal.pmed.1000366
   PubMed Web of Science ®Google Scholar
• Owsley C, Stalvey BT, Phillips JM. 2003. The efficacy of an educational intervention in promoting self-regulation among high-risk older drivers. Accid Anal Prev. 35(3):393–400. doi: 10.1016/s0001-4575(02)00016-7
   PubMed Web of Science ®Google Scholar
• Ramaekers JG. 2017. Drugs and driving research in medicinal drug development. Trends Pharmacol Sci. 38(4):319–321. doi: 10.1016/j.tips.2017.01.006
   PubMed Web of Science ®Google Scholar
• Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LT. 2011. Road traffic accidents and psychotropic medication use in the Netherlands: A case-control study. Br J Clin Pharmacol. 72(3):505–513. doi: 10.1111/j.1365-2125.2011.03994.x
   PubMed Web of Science ®Google Scholar
• Starkey NJ, Charlton SG, Malthotra N, Ameratunga S. 2017. Prevalence of psychotropic drug use prior to driving. J Transp Health. 4:108–117. doi: 10.1016/j.jth.2016.12.004
   Web of Science ®Google Scholar
• Suka M, Odajima T, Kasai M, Igarashi A, Ishikawa H, Kusama M, Nakayama T, Sumitani M, Sugimori H. 2013. The 14-item health literacy scale for Japanese adults (HLS-14). Environ Health Prev Med. 18(5):407–415. doi: 10.1007/s12199-013-0340-z
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Matsumoto K, Kuroda Y, Oohara H, Kizu J. 2016. Pharmacy pharmacist's response to prescription of medicines that affect driving. J Jpn Counc Traffic Sci. 15(3):29–37. doi https://doi.org/10.24597/jcts.15.3_29. (Japanese)
   Google Scholar
• United States Pharmacopoeia. USP pictograms. n.d. [accessed 2018 Dec 1]. http://www.usp.org/health-quality-safety/usp-pictograms.
   Google Scholar
• Wiese Simonsen K, Steentoft A, Bernhoft IM, Hels T, Rasmussen BS, Linnet K. 2013. Psychoactive substances in seriously injured drivers in Denmark. Forensic Sci Int. 224(1–3):44–50. doi: 10.1016/j.forsciint.2012.10.025
   PubMed Web of Science ®Google Scholar
• Wolf JS, Wogalter MS. 1993. Test and development of pharmaceutical pictorials. Proc Interface. 93:187–192.
   Google Scholar